BSE Live
Apr 10, 16:01Prev. Close
25.04
Open Price
25.74
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Panjon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.19 | 0.28 | 0.24 | 0.18 | 0.02 | |
| Net CashFlow From Operating Activities | 0.35 | 0.49 | -0.17 | 0.18 | -0.20 | |
| Net Cash Used In Investing Activities | -0.51 | -0.31 | -0.08 | -0.04 | -0.06 | |
| Net Cash Used From Financing Activities | -0.07 | -0.05 | 0.40 | -0.17 | -0.19 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.22 | 0.13 | 0.15 | -0.03 | -0.44 | |
| Cash And Cash Equivalents Begin of Year | 0.50 | 0.37 | 0.22 | 0.25 | 0.70 | |
| Cash And Cash Equivalents End Of Year | 0.28 | 0.50 | 0.37 | 0.22 | 0.25 |
04.03.2026
Panjon Standalone December 2025 Net Sales at Rs 14.14 crore, up 26.74% Y-o-Y
25.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
14.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
21.08.2025
Panjon Standalone June 2025 Net Sales at Rs 6.42 crore, up 206.63% Y-o-Y
04.03.2026
Panjon Standalone December 2025 Net Sales at Rs 14.14 crore, up 26.74% Y-o-Y
25.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
14.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
21.08.2025
Panjon Standalone June 2025 Net Sales at Rs 6.42 crore, up 206.63% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth